AVITA Medical (AVHHL) EBT Margin (2018 - 2026)
AVITA Medical's (AVHHL) quarterly EBT Margin came in at 35.16% in Q2 2026, up 1868.0% on a YoY basis from 1.79% in Q2 2025, and down 177.93% quarter-over-quarter from 12.65% in Q4 2025.
Powered by 
Analysis
AVITA Medical (AVHHL) EBT Margin (2018 - 2026) Analysis & Trends
AVITA Medical (AVHHL) has reported EBT Margin for 9 consecutive years, with 35.16% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 1868.0% year-over-year to 35.16%; the trailing twelve-month figure through Jun 2026 stood at 28.39% (up 4047.0% YoY), and the FY2025 full-year result was 67.83%, up 2834.0% from the prior year.
- EBT Margin eased to 35.16% in Q2 2026 per AVHHL's latest filing, from 12.65% in the prior quarter.
- Across five years, EBT Margin topped out at 12.65% in Q4 2025 and bottomed at 167.76% in Q1 2024.
- Historically, EBT Margin has averaged 82.1% across 5 years, with a median of 80.13% in 2024.
- The sharpest annual moves came in 2024 and 2025: EBT Margin plunged 8065 bps in 2024, then jumped 9295 bps in 2025.
- Over 5 years, EBT Margin stood at 103.37% in 2022, then fell by 12 bps to 115.74% in 2023, then surged by 46 bps to 62.86% in 2024, then jumped by 80 bps to 12.65% in 2025, then plunged by 178 bps to 35.16% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 35.16%, 12.65%, and 77.2% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.53 Bn | 178.93 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 124.87 Bn | 119.66 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 118.77 Bn | 109.95 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 104.82 Bn | 101.34 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 67.11 Bn | 66.58 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 34.03 Bn | 32.57 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.21 Bn | 20.73 Bn | 684.20 Mn | 18.32% |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | -35.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.16% |
| Dec 31, 2025 | -12.65% |
| Sep 30, 2025 | -77.20% |
| Jun 30, 2025 | -53.84% |
| Mar 31, 2025 | -74.81% |
| Dec 31, 2024 | -62.86% |
| Sep 30, 2024 | -83.05% |
| Jun 30, 2024 | -101.09% |
| Mar 31, 2024 | -167.76% |
| Dec 31, 2023 | -115.74% |
| Sep 30, 2023 | -63.77% |
| Jun 30, 2023 | -88.24% |
| Mar 31, 2023 | -87.11% |
| Dec 31, 2022 | -103.37% |
| Sep 30, 2022 | -61.42% |
| Mar 31, 2022 | -125.47% |
| Sep 30, 2021 | -63.78% |
| Jun 30, 2021 | -56.10% |
| Mar 31, 2021 | -68.31% |
| Dec 31, 2020 | -110.33% |